PG

Prakash Gordhanbhai Ramoliya

Active Director Director DIN 11613905
DIN 11613905 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Prakash Gordhanbhai Ramoliya

Data last updated:

Prakash Gordhanbhai Ramoliya is a Director at Teravito Biotech Private Limited (since 2026).

DIN 11613905
Primary Designation Director
First Appointment 17 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Teravito Biotech Private Limited U20210GJ2026PTC175106
Director17 Mar 20262026Active

Board colleagues of Prakash Gordhanbhai Ramoliya

NameDINCompanyDesignation
Rohit Dhirubhai Ramoliya11613906Teravito Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Teravito Biotech Private Limited
Premium access

Shareholding and investment profile for Prakash Gordhanbhai Ramoliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prakash Gordhanbhai Ramoliya

Prakash Gordhanbhai Ramoliya currently holds 1 directorship: Teravito Biotech Private Limited (Director, since 17 Mar 2026).

Prakash Gordhanbhai Ramoliya was first appointed on 17 Mar 2026 as Director at Teravito Biotech Private Limited.

The current boards of Prakash Gordhanbhai Ramoliya's companies include Rohit Dhirubhai Ramoliya (Teravito Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available